CORT001
Latest Information Update: 30 Apr 2013
At a glance
- Originator Cortendo
- Class Pregnenediones
- Mechanism of Action Steroid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Metabolic syndrome
Most Recent Events
- 30 Apr 2013 Discontinued - Phase-II for Metabolic syndrome in USA (unspecified route)
- 21 Oct 2002 Phase-II clinical trials in Metabolic syndrome in USA (unspecified route)